DiaMedica Therapeutics Inc. (NASDAQ: DMAC)
$3.48
-0.1000 ( -2.79% ) 22.1K
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
Market Data
Open
$3.48
Previous close
$3.58
Volume
22.1K
Market cap
$144.90M
Day range
$3.32 - $3.58
52 week range
$1.94 - $4.33
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
8-k | 8K-related | 15 | May 23, 2024 |
10-q | Quarterly Reports | 62 | May 08, 2024 |
8-k | 8K-related | 16 | May 08, 2024 |
8-k | 8K-related | 14 | Apr 10, 2024 |
ars | Annual reports | 1 | Apr 04, 2024 |
def | Proxies and info statements | 11 | Apr 04, 2024 |